CDAKQ — Codiak BioSciences,. Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.06m
- -$26.01m
- $22.94m
Annual cashflow statement for Codiak BioSciences,., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27 | -44.5 | -78 | -91.7 | -37.2 |
| Depreciation | |||||
| Non-Cash Items | 2.5 | 13.2 | 6.58 | 10.1 | -22.6 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.786 | -0.928 | 66.9 | 13.9 | -19.7 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -23.9 | -30.6 | -1.7 | -63.4 | -74.1 |
| Capital Expenditures | -2.94 | -8.32 | -10.5 | -21.1 | -3.25 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -70.2 | -1.19 | 73.1 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.94 | -78.5 | -11.7 | 52 | -3.25 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 76.4 | -0.058 | 9.76 | 89.6 | 65.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 49.5 | -109 | -3.61 | 78.2 | -12 |